TRANSKRIBEERI 🔗
WEBVTT
00:00:00.160 --> 00:00:02.640
This podcast is designed to inform and inspire discussion.
00:00:02.720 --> 00:00:07.440
It should never replace individual patient assessment, professional judgment, or current evidence-based practice.
00:00:07.679 --> 00:00:16.879
Welcome to Wundcare Unwrapped, the podcast that peels back the layers of wound care to uncover what's working, what isn't, and what needs to change.
00:00:17.120 --> 00:00:19.039
So let's unwrap it.
00:00:31.199 --> 00:00:37.359
I'm Hayley Ryan, the Director of Wound Rescue, and this podcast is produced in partnership with Learn on the Move.
00:00:37.600 --> 00:00:41.439
Today I'm joined by Associate Professor Sof Andrew.
00:00:41.679 --> 00:00:43.200
I'm going to do that again, Lainey.
00:00:43.439 --> 00:00:50.880
I knew your I'm Hayley Rine, the Director of Wound Rescue, and this podcast is produced in partnership with Learn on the Move.
00:00:51.119 --> 00:01:04.879
Today I'm joined by Associate Professor Sof Andrew Coppolis, Group Chief Executive Officer of the Australian Diabetes Society and one of Australia's leading voices in diabetes research, policy, and clinical care.
00:01:05.280 --> 00:01:23.920
Sof has previously served as President and Treasurer of the Australian Diabetes Society and before moving into leadership, headed the Islid Biology and Metabolism Research Group at the University of Melbourne, investigating mechanisms behind beta cell dysfunction and type 2 diabetes.
00:01:24.159 --> 00:01:38.879
He has published extensively in the causes and management of type 2 diabetes and has played a major role in national initiatives, including diabetes guidelines, continuous glucose monitoring and advocacy and the foot forward program.
00:01:39.519 --> 00:01:45.519
So today we're going to step back from the diabetic foot and talk about diabetes itself.
00:01:45.760 --> 00:01:48.400
What actually causes type 2 diabetes?
00:01:48.560 --> 00:01:49.519
Can we prevent it?
00:01:49.760 --> 00:01:51.120
Can we reverse it?
00:01:51.439 --> 00:01:54.480
Are we diagnosing and treating it early enough?
00:01:54.640 --> 00:02:08.080
And with CGMs and GLP1s and increasingly sophisticated medications and technology, are we generally changing the trajectory of diabetes or are we just getting better at managing it?
00:02:08.240 --> 00:02:19.759
And importantly, for wound clinicians, what do we really need to understand about diabetes to prevent the complications we eventually see at the wound end of the healthcare system?
00:02:20.080 --> 00:02:22.879
So that's a lot to get through, but let's unwrap it.
00:02:23.039 --> 00:02:25.120
Soph, welcome to woundcare unwrapped.
00:02:25.199 --> 00:02:27.120
It's so great to have you with us.
00:02:27.759 --> 00:02:30.080
Thanks, uh Haley, and thank you for the introduction.
00:02:30.159 --> 00:02:31.439
I'm actually humbled.
00:02:31.520 --> 00:02:36.400
Uh but uh thank you, and I'm really excited and really happy to be here to talk about diabetes.
00:02:36.719 --> 00:02:37.120
Thank you.
00:02:37.199 --> 00:02:41.360
We're really humbled to have you on the show because you bring such a wealth of knowledge.
00:02:41.439 --> 00:02:43.680
And maybe let's start there, Soph.
00:02:43.759 --> 00:02:46.719
What first drew you into diabetes research?
00:02:47.199 --> 00:03:02.000
Well, look, uh, I'm gonna go way back and I'm gonna say that I've always been interested in science and I've always been uh curious and I've always been um sort of looking at things uh in a little different way.
00:03:02.159 --> 00:03:06.159
In actual fact, and I've got it right here next to me because I knew this question was coming.
00:03:06.400 --> 00:03:13.039
This is my first microscope that my parents bought me when I was seven years old, and I still have it.
00:03:13.199 --> 00:03:22.080
I still have it because it it reminds me that I've always been interested in science and in research.
00:03:22.400 --> 00:03:31.840
And um, you know, I I I achieved my my sort of goal, you know, going into research.
00:03:32.080 --> 00:03:39.120
So so for me, it's been a lifelong passion to do research.
00:03:39.520 --> 00:03:48.159
Um, you know, and and I had a very linear path in my in my sort of research uh uh career.
00:03:48.319 --> 00:03:51.599
I did an undergrad and then I did a a PhD.
00:03:51.840 --> 00:03:58.560
And I um I didn't necessarily choose diabetes, we sort of chose each other.
00:03:58.719 --> 00:04:02.879
Uh when I finished my undergrad, uh I was looking for a research project.
00:04:03.039 --> 00:04:06.240
I wanted to do science, I was always interested in research.
00:04:06.560 --> 00:04:14.560
And um uh Joe Priotto, who was my uh supervisor mentor, needed somebody to do a project.
00:04:14.800 --> 00:04:16.800
And so we came together.
00:04:17.040 --> 00:04:24.399
And I must say, uh, when I entered the lab, the first day I entered the lab, I got this infection.
00:04:24.560 --> 00:04:26.399
I call it the bug.
00:04:26.639 --> 00:04:28.959
I got the research bug and I was hooked.
00:04:29.120 --> 00:04:37.759
I was and I've been hooked forever, and and it's it's it's a it's an infection or a bug that um you can't get rid of.
00:04:37.839 --> 00:04:39.199
You know, it's it's with you.
00:04:39.360 --> 00:04:42.720
It's a wonderful, it's it's the one bug that you want.
00:04:43.199 --> 00:04:45.199
It's the one we don't want to cure us off.
00:04:45.279 --> 00:04:46.639
We want you to hold on to that.
00:04:49.519 --> 00:04:58.160
If we think about your early years, and that's such a great segue, you your early research really focused on pancreatic beta cell dysfunction.
00:04:58.399 --> 00:05:04.160
What have we learned about why some people develop type 2 diabetes and others don't?
00:05:04.560 --> 00:05:04.879
Right.
00:05:04.959 --> 00:05:16.879
So um I my PhD and uh you know the uh I did a lot um in beta cell dysfunction and insulin secretion, but my actual PhD was on insulin resistance.
Load full transcript
00:05:17.040 --> 00:05:28.639
So I did a lot of liver metabolism uh and glucaneesis and uh measuring enzymes and doing euglycemic hyperinsulinemic clamps in uh in mice to look at insulin resistance.
00:05:28.800 --> 00:05:39.040
So my first foray and my first sort of exposure to diabetes, type 2 diabetes, was all about insulin resistance.
00:05:39.360 --> 00:06:05.120
Uh, and then I did a postdoc at the University of Washington in Seattle with uh this doyen of diabetes called Daniel Port, who put me together with a young Stephen Khan at the time, and we did bitter cell dysfunction because Dan Port was very much interested in the etiology of type 2 diabetes.
00:06:05.759 --> 00:06:52.240
And it turns out that uh, and we'll we'll probably get to this at some point, it turns out that you can't get hypoglycemia or diabetes without a defect in insulin secretion, irrespective of which type of diabetes you look at, whether it's type 1 or type 2, or gestational diabetes, or any forms of uh maturity on diabetes of the youth, MODI, or any other of the rarer conditions, uh rarer types of diabetes, penicillin dysfunction is the sort of cause of it, or impaired insulin secretion or reduced insulin secretion in a prevailing insulin resistance state, which is type 2 diabetes, is the cause of the hypoglycemia.
00:06:52.720 --> 00:06:53.360
Hmm.
00:06:53.680 --> 00:06:57.519
Yeah, that's really set the foundations for today's topic.
00:06:57.680 --> 00:07:02.800
So, all right, sof, we're gonna start with a segment we call clinical confessions.
00:07:02.959 --> 00:07:11.759
And I want to know what's something about diabetes that you were taught maybe earlier in your career that the evidence has since made you rethink?
00:07:12.240 --> 00:07:12.879
Right.
00:07:13.199 --> 00:07:32.240
So uh my um my PhD thesis says, yeah, the mechanism of hepatic uh glucose overproduction uh in an animal model of non-insulin-dependent diabetes, NIDDM.
00:07:32.720 --> 00:07:37.759
So we used to call type 2 diabetes uh non-insulin dependent, and that's not true.
00:07:37.920 --> 00:07:42.800
And we know that the evidence shows that a lot of people with type 2 diabetes use insulin.
00:07:42.959 --> 00:07:49.759
A lot of uh people with type 2 diabetes require insulin to manage their uh blood glucose levels.
00:07:49.839 --> 00:07:57.519
Uh type 2 diabetes is probably a progressive disease, uh likely a progressive disease where insulin plays an important role.
00:07:57.680 --> 00:08:08.240
So I I would say calling it NIDDM, non-insulin-dependent diabetes mellitus, was uh probably something that now we know is not correct.
00:08:08.399 --> 00:08:20.560
Yeah, and and if I can add, the other thing is, you know, when when I started in diabetes 1989, uh type 2 diabetes was, or NIDDM was an old person's disease, right?
00:08:20.720 --> 00:08:23.680
So we'd say, oh, over the age of 60 or 65.
00:08:23.920 --> 00:08:25.600
And we know that that's not true.
00:08:25.759 --> 00:08:32.240
We know
that people can get type 2 diabetes uh much younger, and we can get type 2 diabetes in our teens.
00:08:32.320 --> 00:08:37.919
You know, there's there's there's reports of uh people very young getting type 2 diabetes.
00:08:38.000 --> 00:08:39.679
Probably those two, I would say.
00:08:40.399 --> 00:08:42.399
Yeah, and look, I have to agree, Soph.
00:08:42.480 --> 00:08:48.320
We still see knittim, and that's how it's generally pronounced, NID DM written everywhere.
00:08:48.559 --> 00:08:50.480
Every wound tells a story.
00:08:50.720 --> 00:08:53.200
But it should never end with someone giving up.
00:08:53.360 --> 00:09:03.679
At Wound Rescue, our master's qualified clinicians provide advanced bedside wound care across Australia, helping restore mobility, independence, and confidence.
00:09:03.840 --> 00:09:09.279
Because healing isn't just closing skin, it's helping people get their lives back.
00:09:09.519 --> 00:09:16.879
Call 1-300-193-195 or visit woundrescue.com.au today.
00:09:17.840 --> 00:09:28.399
So thinking about healthcare providers that might be listening in to this podcast, what would you really like them to stop doing from their next shift?
00:09:29.200 --> 00:09:39.360
Look, I I I think uh, you know, type 2 diabetes is a genetic predisposition to bitter cell failure.
00:09:39.600 --> 00:09:46.559
So I think if we can um understand that you know genetics play a really important role.
00:09:46.799 --> 00:10:03.200
I think if we can if we cannot stigmatize type 2 diabetes, uh I think that would go a very long way in providing uh really good care for the person uh that comes into your clinical practice with type 2 diabetes.
00:10:03.679 --> 00:10:08.480
Yeah, I love that because it's not just all bad diet as we tend to hear about.
00:10:08.639 --> 00:10:10.399
So you're so right, Soph.
00:10:10.799 --> 00:10:12.960
Um look, let's go there then.
00:10:13.120 --> 00:10:22.559
We we talk about insulin resistance all the time, but what's actually happening physiologically when someone develops, say, type 2 diabetes?
00:10:22.960 --> 00:10:23.200
Right.
00:10:23.279 --> 00:10:35.600
So so I think it it's it's um, I guess uh we're gonna make generalizations here, but you know, every person's got their own um journey, their own personal journey.
00:10:35.919 --> 00:10:47.519
But in general, what happens is that uh there's a state of insulin resistance, and perhaps that state of insulin resistance is environmental.
00:10:48.000 --> 00:10:52.720
Uh, and then there is a demand on the beta cell to secrete insulin.
00:10:52.799 --> 00:11:05.919
So there is um a stage where there's hypersecretion of insulin, uh, but because there's a predisposition uh to beta cell failure, that hypersecretion cannot be sustained.
00:11:07.120 --> 00:11:09.519
I I sometimes say the fuse blows.
00:11:09.840 --> 00:11:18.320
So you know your genetic predisposition kicks in and you start secreting less and less insulin and your blood glucose levels rise.
00:11:18.480 --> 00:11:33.120
So the way that I would explain it is that um your insulin resistance brings out and masks your genetic predisposition to diabetes in uh when it comes to type 2 diabetes.
00:11:33.279 --> 00:11:36.320
So insulin resistance is important, yes, of course.
00:11:36.720 --> 00:11:40.480
You cannot get diabetes purely on insulin resistance.
00:11:40.879 --> 00:11:49.519
If if that was true, all of the people with obesity and overweight would have diabetes, and they don't.
00:11:49.840 --> 00:11:55.679
Yeah, in Australia, there's about 33% of the adult population that are living with obesity.
00:11:55.919 --> 00:12:02.320
Uh, the adult population of type 2 does is about 5%.
00:12:03.039 --> 00:12:11.440
So those two numbers would be a lot closer if it was just purely on insulin resistance or bad habits or or diets and so on.
00:12:11.600 --> 00:12:21.600
So clearly, genetic predisposition plays uh uh a significant role, and that predisposition is to losing um beta cell function.
00:12:23.279 --> 00:12:29.039
That that's a good point and a visual for everyone that's listening in to think about, you know, if that was the case.
00:12:29.200 --> 00:12:39.840
So look, um, by the time someone's HBA1C crosses that diagnostic threshold, how long has that disease process potentially been developing then?
00:12:40.240 --> 00:12:41.919
Yes, uh very good question.
00:12:42.000 --> 00:12:45.279
So I'm not sure, and it's not quite clear, yeah.
00:12:45.440 --> 00:12:50.399
With type 1 diabetes, it's it's uh most often very acute.
00:12:50.639 --> 00:12:52.879
Uh person feels very ill.
00:12:53.039 --> 00:13:00.240
Uh they probably haven't had a prolonged period of hypoglycemia or undiagnosed diabetes.
00:13:00.639 --> 00:13:04.080
Um uh with type 2 diabetes, we don't know.
00:13:04.240 --> 00:13:15.120
Um the problem there's you know, there's an estimate there's maybe half a million Australians or maybe more who are undiagnosed with type 2 diabetes today.
00:13:15.200 --> 00:13:27.279
Uh and because they haven't gone to the doctor, because their the symptoms aren't as acute uh uh uh as they are, say, when your glucoses go up to 2025.
00:13:27.600 --> 00:13:35.360
Uh so so people probably are are walking around with higher glucose levels and they don't know it.
00:13:35.519 --> 00:13:36.320
A lot of people.
00:13:37.279 --> 00:13:38.080
I don't know.
00:13:38.240 --> 00:13:40.159
The answer is we don't know.
00:13:40.639 --> 00:13:46.799
So then, based off that, we could potentially be diagnosing type 2 diabetes rather late.
00:13:47.360 --> 00:13:51.360
Yeah, yeah, in certain circumstances, I I think I think that's right.
00:13:51.600 --> 00:14:06.240
Uh many years ago, we did a uh a trial, a screening trial, the pharmacy diabetes screening trial with the pharmacy guild, uh, and it was looking at uh trying to screen the general population.
00:14:06.480 --> 00:14:20.159
And that revealed, if I'm not correct, uh if I'm not mistaken, that
revealed, you know, 1.5% of the general population uh had diabetes and didn't know it.
00:14:20.399 --> 00:14:37.919
There's another study that uh the Austin uh hospital did, the diabetes discovery study, uh they published a number of years ago now, where they screened every single person that came into hospital over the age of 54 for diabetes.
00:14:38.000 --> 00:14:46.639
And they found that about 5% of the people that they screened had undiagnosed diabetes.
00:14:46.879 --> 00:14:53.440
Uh, and you know, about 34% of inpatients uh had diabetes.
00:14:53.759 --> 00:14:59.360
So we can put together programs to actually screen.
00:14:59.519 --> 00:15:14.559
I think we can we can put together uh uh more educational or or um uh uh programs to increase the um importance of getting yourself uh uh regularly checked.
00:15:14.639 --> 00:15:32.960
Uh we can get um um GPs to be a little bit more aware and to say to somebody who comes in for, I don't know, let's just say they come in for the flu injection, have you have you done your uh blood glucose test or just general tests, uh blood tests?
00:15:33.039 --> 00:15:35.039
Let's do one and see how we go.
00:15:36.320 --> 00:15:43.279
Is there anything in the research soft that makes recommendations for how often that kind of testing should be done at the GP?
00:15:43.440 --> 00:15:47.039
Are there any signs and symptoms that clinicians listening should be thinking about?
00:15:47.360 --> 00:15:48.720
Yeah, I I I think so.
00:15:48.799 --> 00:16:01.759
If you if you're thinking about signs and symptoms, you know, we talk about the four T's, which is first uh tiredness, going to the toilet a lot, and losing weight without actually wanting to lose weight.
00:16:01.840 --> 00:16:12.159
Uh, if you've got a family history of of of diabetes, type 2 diabetes, uh, that often uh increases your likelihood of getting diabetes if you're overweight.
00:16:12.240 --> 00:16:23.440
Uh, if you're from um certain ethnic backgrounds where diabetes uh prevalence is high, if you're an Aboriginal Torres Islander person.
00:16:24.320 --> 00:16:32.559
We do have a screening uh tool, it's called the OSD Risk, uh, which is a questionnaire that uh people can fill in.
00:16:32.639 --> 00:16:35.039
I think you can do it even online, fill it in.
00:16:36.000 --> 00:17:05.599
You know, if you're if you're over the age of 40, you know, you should be sort of doing this uh uh on an annual basis, probably, uh, to be able to then pick it up uh and and and pick up if you if you've got hyperglycemia or pre-diabetes, which is probably where you want to sort of act and and act um um accordingly to to try and delay uh or prevent the progression to type 2 diabetes.
00:17:06.480 --> 00:17:14.559
And maybe um let's just touch on say gestational diabetes because it might be your 21-year-olds, not those over the age of 40.
00:17:14.720 --> 00:17:17.119
What what should GPs be thinking about?
00:17:17.279 --> 00:17:22.240
When should they take some diagnostics and maybe are there different side effects for those patients?
00:17:24.319 --> 00:17:27.359
So you've opened up now a huge can of worms.
00:17:27.519 --> 00:17:38.559
So so uh we we've worked with Australasian Diabetes and Pregnancy Society, ADIPS uh recently that have updated their uh GDM screening guidelines.
00:17:38.960 --> 00:18:05.359
Uh we still feel that uh doing an OGDT, an old glucose tolerance test in the second trimester, 20 to 24 weeks of age, to try and identify uh women who uh may have hyperglycemia andor gestational diabetes to then be able to um manage that appropriately.
00:18:05.680 --> 00:18:26.160
There are certain circumstances where uh you would screen earlier if there's uh a high risk, if you've had uh gestational diabetes in a previous pregnancy, if you're from uh certain ethnic backgrounds, you may want to get uh screened at 14 weeks.
00:18:26.400 --> 00:18:33.200
The evidence for screening at 14 weeks is a lot weaker than the evidence to screen at 20 to 24 weeks.
00:18:33.359 --> 00:18:38.000
Uh Haley, a very um dynamic.
00:18:38.079 --> 00:18:41.759
Let's just say, I was gonna say controversial, uh uh bleep that out.
00:18:41.920 --> 00:18:43.759
Not controversial, very dynamic.
00:18:43.839 --> 00:18:59.599
It's a very dynamic field, and I think a very important field because we do know that having gestational diabetes increases your risk of type 2 diabetes in the next 10 years by about, say, 40%, and it also has implications on the baby as well, right?
00:18:59.680 --> 00:19:00.640
So yes.
00:19:01.119 --> 00:19:07.839
Yeah, well, that that certainly opened up a very good can so that others can who are listening in take that information.
00:19:08.079 --> 00:19:12.640
So, look, soft, we're increasingly hearing the term diabetes remission.
00:19:13.119 --> 00:19:15.279
What does remission actually mean?
00:19:15.759 --> 00:19:26.400
Look, uh for me, diabetes remission means uh when your uh HPA1C or your fast or your HBA1C is below 6.5 so uh percent.
00:19:26.559 --> 00:19:39.279
So we diagnose diabetes with a HBA1C, and the HBA1C is uh 6.5 or higher, you've got uh type 2 or diabetes.
00:19:39.440 --> 00:19:44.799
If the the your HPR1C is less than 6.5, then you don't have diabetes.
00:19:44.880 --> 00:19:56.640
So for me, it is about having your HBI1C below 6.5, and you can do that by for me again by any means.
00:19:56.799 --> 00:20:15.920
So you can do it by lifestyle and losing weight, you can do it with pharmacotherapy, you can do it with bariatric metabolic surgery, you can do it whichever way is the right way for you as an individual to get your HPM1C below 6.5.
00:20:16.880 --> 00:20:19.519
And so that's the goal for most patients, right?
00:20:19.599 --> 00:20:23.359
And so that's through lifestyle choices, is that what you're saying?
00:20:23.759 --> 00:20:30.559
Well, it's it should be the goal for people who have uncomplicated diabetes.
00:20:30.799 --> 00:20:35.200
So I think again, we need to
make sure that it's the right person that would manage.
00:20:35.359 --> 00:20:52.319
So if you've got a an elderly person uh who's got multiple uh complications, who is in care, uh uh who um is has other issues, HPL and C of 6.5 may be completely and utterly unrealistic.
00:20:52.640 --> 00:20:54.880
And in actual fact, could be dangerous.
00:20:55.039 --> 00:21:09.680
But I think if you're a young person um where you haven't had diabetes for a very long time, you've got a long uh uh life expectancy, you have uh a much lower burden of complications than it is.
00:21:10.960 --> 00:21:17.200
Um it is reasonable to say let's try and get remission.
00:21:17.839 --> 00:21:18.160
Hmm.
00:21:18.319 --> 00:21:28.160
Okay, so then from what I'm hearing, and correct me if I'm wrong, Soph, it it's become almost synonymous that how we judge diabetes control is through that HBA1C.
00:21:28.240 --> 00:21:32.240
So does HBA1C sometimes give us false reassurance?
00:21:32.640 --> 00:21:33.759
Well, yes, yes.
00:21:33.839 --> 00:21:41.039
Uh HBA1C is a measure of your of your glucose management over the last 12 weeks.
00:21:41.200 --> 00:21:48.480
So it doesn't give you the day to day um variations or fluctuations in in blood glucoses.
00:21:48.799 --> 00:22:00.880
Uh so you may be a person that has a very nice HBI1C of and an acceptable HBA1C of 7.1 or 7.2, and people go, okay, that's That's not too bad.
00:22:00.960 --> 00:22:02.000
That's acceptable.
00:22:02.400 --> 00:22:03.680
It could be a lot worse, of course.
00:22:03.920 --> 00:22:06.400
But you're getting a lot of hypos at night.
00:22:06.480 --> 00:22:08.319
And that's not acceptable, right?
00:22:08.480 --> 00:22:10.240
Or you're going really high.
00:22:10.400 --> 00:22:14.240
You're getting very high sugars after your meal or something, right?
00:22:14.319 --> 00:22:22.559
And again, that's not acceptable because either way, we know that that affects your complications and your risk of complications.
00:22:22.720 --> 00:22:35.359
So HBA1C is not the complete picture, but it's it's a good way to assess um blood glucose management.
00:22:36.640 --> 00:22:44.559
So then, Soph, you and I could have the exact same high HBA1C, the exact same number, but very different glucose profiles.
00:22:44.720 --> 00:22:45.839
We respond differently.
00:22:46.000 --> 00:22:46.799
That's what I'm hearing.
00:22:46.880 --> 00:22:47.039
Yeah.
00:22:47.440 --> 00:22:48.160
Totally correct.
00:22:48.319 --> 00:22:48.799
Absolutely.
00:22:48.960 --> 00:22:54.559
You may have a very flat profile, and I may be going like this up and down and up and down and up and down.
00:22:54.640 --> 00:23:03.200
And my glucose may be varying quite quite uh significantly, and yet our HPA1s are the same at 7.1 or 7.2.
00:23:04.000 --> 00:23:08.240
My situation will be a lot worse than yours because you've got a very flat profile.
00:23:08.319 --> 00:23:11.119
Uh, and my risk of complications will be higher.
00:23:11.279 --> 00:23:17.839
And the fact that I'm hypoing uh a lot is dangerous for all sorts of reasons, right?
00:23:17.920 --> 00:23:18.160
Yeah.
00:23:18.480 --> 00:23:19.039
Yeah.
00:23:19.279 --> 00:23:29.440
And taking that holistic personal approach as well, you might have different disease processes, you might have a different lifestyle of where you live socioeconomically, all of these things play into it.
00:23:29.599 --> 00:23:33.039
So um you mentioned, I think, before CGM.
00:23:33.200 --> 00:23:40.480
Can you tell us about CGM and are technologies such as CGM going to change the way we think about diabetes control?
00:23:41.279 --> 00:23:51.119
Yes, I think continuous glucose monitors are a way that somebody can measure their blood glucose on a continuous manner.
00:23:51.359 --> 00:24:17.359
So you get uh your level of blood glucose um I think every five minutes or or thereabouts, so much more continuously, or much you have a much complete picture of what you're doing and how food uh affects your glucose, how exercise affects your glucose, how fasting affects your glucose, how stress affects your glucose, you know, the the choices that you make affect your glucose.
00:24:17.440 --> 00:24:23.839
So it's a good way to actually make those changes to try and have a more flat profile.
00:24:24.000 --> 00:24:29.279
You can only finger prick your finger, you can only prick your finger so many times, right?
00:24:29.680 --> 00:24:35.279
Whereas a CGM really gives you uh a much more complete picture.
00:24:35.359 --> 00:24:43.599
I I sort of liken it to uh going to a room and your finger pricking is looking through the keyhole.
00:24:43.680 --> 00:24:49.680
Uh, whereas your CGM is you've and you can only see with through the keyhole, you can only see a certain amount of the room.
00:24:49.759 --> 00:24:54.880
Uh whereas with your CGM, you've opened the door and you can see the comp the hole in the complete room.
00:24:55.279 --> 00:25:02.720
Yeah, and look, we use those continuous glucose monitoring monitoring now a lot for our type one diabetic management.
00:25:02.880 --> 00:25:06.240
Um, what is there a role maybe for type two as well?
00:25:06.640 --> 00:25:07.440
There certainly is.
00:25:07.519 --> 00:25:14.880
So in Australia, uh uh CGM, continuous glucose monitors are subsidized uh for people with type 1 diabetes.
00:25:15.039 --> 00:25:22.799
We don't have a subsidization for people with type 2, but we are advocating, and I I am optimistic.
00:25:22.960 --> 00:25:31.599
Uh I am uh positively optimistic that we will get subsidization for people with type 2 diabetes, particularly if they're on insulin.
00:25:31.759 --> 00:25:40.880
Uh, and I think you know, people who are using insulin to manage their blood glucose levels should have access to subsidized uh CGM.
00:25:40.960 --> 00:26:06.400
The evidence is very uh clear that you'll get much better uh blood glucose management and you will prevent hypoglycemia, you will prevent DKA, which is the other side, you
will prevent hospitalizations for the people who are using insulin, whether you're type 1 or type 2, to manage your diabetes uh where the risk of hypose is significantly elevated.
00:26:07.440 --> 00:26:09.119
It's real-time care, right?
00:26:09.279 --> 00:26:15.039
So, you know, what I see in front of me makes me stop, think, reevaluate, and change my my own actions.
00:26:15.119 --> 00:26:16.319
So it's important.
00:26:16.480 --> 00:26:29.839
Um, look, Soph, we can't have a conversation about modern diabetes, diabetic care without talking about these GLP1 receptor agonists and the newer therapies coming to fruition very quickly.
00:26:30.079 --> 00:26:37.359
Have these medications fundamentally changed type 2 diabetes in terms of management?
00:26:38.480 --> 00:26:39.039
Totally.
00:26:39.359 --> 00:26:50.480
I think we're in a an absolutely exciting uh uh disease modifying time.
00:26:50.960 --> 00:27:00.480
I think the GLP1 based therapies are at the moment revolutionizing the management of type 2 diabetes.
00:27:01.119 --> 00:27:08.400
Um we've got uh one agent that's been subsidized for type 2 diabetes in Australia.
00:27:08.559 --> 00:27:22.000
There's a second uh dual agonist that's sort of in the mix and trying to get subsidization, and then there's I don't know, a hundred others uh coming.
00:27:22.400 --> 00:27:33.920
Uh injectables, orals, peptides, uh non-peptide synthetics, uh, dual agonist, uh triple agonists, quadruple agonists, you name it.
00:27:34.079 --> 00:27:35.119
It's coming.
00:27:35.279 --> 00:27:48.160
Uh, and you know, I'm going to the European uh diabetes meeting in Milan in a couple of weeks, and I don't know, maybe half the program is about these new GLP1-based therapies.
00:27:48.400 --> 00:28:21.200
They will completely revolutionize uh, or they are, I should say they are revolution revolutionizing type 2 diabetes management and obesity, not only because they cause weight loss and better blood glucose management, but they've shown to protect your heart, you protect your kidney, um, they reduce sleep apnea, they reduce fatty liver disease, they reduce uh chronic pain, uh, you know, peripheral artery disease.
00:28:21.440 --> 00:28:31.359
So there's uh a study called Stride where uh a GLP1 um agonist has been shown to improve uh peripheral artery disease.
00:28:31.440 --> 00:28:33.119
I mean, you know, wow.
00:28:33.519 --> 00:28:34.880
Wow, wow, wow.
00:28:35.279 --> 00:28:36.160
That's all I can say to that.
00:28:39.759 --> 00:28:55.599
I was even reading a recent study about um addiction and how, because of the process that these GLP ones are having on the hippocampus of the brain and how it's lowering the inhibition to even um, you know, drink alcohol or gamble.
00:28:55.759 --> 00:28:58.880
Like this is revolutionary, you know, we've entered a different world.
00:28:59.039 --> 00:29:00.160
And I agree, Soph.
00:29:00.240 --> 00:29:10.240
I was recently at a health ed conference and there was like 2,000 GPs and all of the trade area, every second second trade setup was a GLP one company.
00:29:10.720 --> 00:29:11.119
That's right.
00:29:12.960 --> 00:29:16.640
I mean, I think for us invented Yeah, totally.
00:29:16.720 --> 00:29:27.279
I think for us and and for primary care and secondary care, at some point we're gonna have to figure out um where uh these agents fit.
00:29:27.519 --> 00:29:28.880
How are we going to use them?
00:29:29.039 --> 00:29:33.519
Are we going to use them for blood glucose diabetes management uh primarily?
00:29:33.599 --> 00:29:35.599
Are we using them for weight loss primarily?
00:29:35.839 --> 00:29:38.799
Are we using them to reduce uh PAD?
00:29:39.039 --> 00:29:41.839
Are we using them to reduce fatty liver disease?
00:29:41.920 --> 00:29:49.440
Uh how, you know, or uh yeah, it's gonna be weight and fatty liver, or weight and peripheral artery disease.
00:29:49.519 --> 00:30:00.960
I mean, we're just gonna have to think about um the way that we position these uh therapies because they are truly life-changing therapies.
00:30:01.920 --> 00:30:07.519
So then on that note, does anything concern you about the way they're currently being used?
00:30:08.160 --> 00:30:22.160
Uh no, I I think uh we we in Australia, because we've got um the the PBS, uh we've got at least one uh um option on the PBS.
00:30:22.559 --> 00:30:29.440
Uh one we've got a couple, but one option that probably is is is a very good option.
00:30:29.599 --> 00:30:33.279
I think we need to think about uh more options.
00:30:33.359 --> 00:30:34.880
We need to give people more options.
00:30:34.960 --> 00:30:44.799
So I so I would be encouraging the government to be subsidizing more than just the one uh or couple of uh medications that we have on the on the PBS.
00:30:44.960 --> 00:30:54.160
I I think then we need to uh ensure that uh healthcare professionals are um educated, upskilled about using them.
00:30:54.319 --> 00:31:17.519
You know, there are some um there are some side effects, yeah, gastrointestinal mostly, um, and how to manage gastrointestinal side effects, you know, um timing of meals, maybe smaller meals, the type of foods uh that may be giving you that uh yucky feeling uh in the stomach.
00:31:17.759 --> 00:31:22.640
Um but I but I'm I'm not terribly worried about the use of them.
00:31:22.799 --> 00:31:26.720
Uh there's a fair bit of off-label use in Australia as well.
00:31:26.880 --> 00:31:43.119
Uh and that's appropriate, I think, because they are such powerful uh medications, they should be used for uh you know obesity, they should be used for obesity-related complications, absolutely, because they are changing people's lives.
00:31:43.759 --> 00:31:44.160
Yeah.
00:31:44.799 --> 00:31:49.680
I I think almost every second person's on one now, if I think about the patients that we're seeing.
00:31:49.839 --> 00:31:55.119
And one big thing that stands out for me is the muscle wastage, the changes to bone structure.
00:31:55.279 -->
00:31:59.119
But it comes down, no medication comes without side effects.
00:31:59.200 --> 00:32:01.359
So know the side effects and manage accordingly.
00:32:01.440 --> 00:32:10.960
And I'm always saying to patients time to refer to a dietitian and get their input into good food choices for protein and other macronutrients.
00:32:11.359 --> 00:32:13.440
Dietitian exercise physiologist.
00:32:13.599 --> 00:32:32.000
So uh I tell people that a lot of these side effects are side effects of weight loss, and that weight loss could be through sort of dietary means, it could be through bariatric surgery, it could be through uh uh medications like these GLP ones.
00:32:32.160 --> 00:32:42.880
So this relative uh lean mass loss or muscle mass loss uh will be uh the same as if you had bariatric surgery to lose your weight.
00:32:43.039 --> 00:32:46.400
So then what you need to do and think about is diet.
00:32:46.559 --> 00:32:49.200
Am I having the appropriate nutrition?
00:32:49.359 --> 00:32:54.799
Am I having enough protein to maintain uh my uh my muscle mass?
00:32:54.880 --> 00:33:03.839
And then am I doing my strength exercises, which helps, as you know, with both your bones and and your strength, your muscle strength.
00:33:04.000 --> 00:33:12.559
I think mass is one thing, but I I think it's uh more important is actually strength, muscle strength will be more important.
00:33:13.279 --> 00:33:26.720
And we're not saying get out there and start lifting 100 kilo weights, it's more resistance training and getting the bone a bit of resistance and the muscle so that it keeps building muscle memory and healing in that capacity or growing the muscle.
00:33:26.880 --> 00:33:29.680
Um, I stand with you around advocacy soft.
00:33:30.000 --> 00:33:40.720
We need to advocate to our government and the world to lower the cost of some of these drugs because another reality is we're seeing a lot on the black market and they are unregulated.
00:33:41.039 --> 00:33:44.160
We don't know what people are getting access to or what they're even taking.
00:33:44.240 --> 00:33:45.920
So we'd caution against that.
00:33:46.000 --> 00:33:47.039
I think you would agree.
00:33:47.519 --> 00:33:58.400
I totally, you know, I um uh the the car wash guy uh last week was telling me uh he's on RETA, RETA Trute, and I go to him, how's that work?
00:33:58.559 --> 00:34:00.880
You know, it's not available, it's still experimental.
00:34:00.960 --> 00:34:03.200
I don't even think it's available anywhere in the world.
00:34:03.279 --> 00:34:06.720
He goes, Ah, no, no, man, I'm getting it off the internet.
00:34:06.799 --> 00:34:08.559
And it's like, okay.
00:34:09.039 --> 00:34:10.239
Uh are you sure?
00:34:10.400 --> 00:34:19.760
So, yes, there are people that are buying something, and we don't know what that is exactly, uh from the internet.
00:34:20.159 --> 00:34:23.360
I would caution anybody from doing that.
00:34:23.679 --> 00:34:32.079
Um, be careful, uh, be mindful that you don't exactly know what you're getting and what's in the actual um components of it.
00:34:32.159 --> 00:34:35.360
Yeah, components of it, whatever it is.
00:34:35.440 --> 00:34:44.719
Uh uh, I I think you know you're you're increasing the risk of doing something more harmful to yourself than than benefit.
00:34:44.880 --> 00:34:46.800
Uh uh please be careful.
00:34:46.880 --> 00:34:48.559
Please, please uh don't do that.
00:34:48.719 --> 00:34:50.480
Just please don't just don't do it.
00:34:50.639 --> 00:34:51.440
Don't do it.
00:34:51.920 --> 00:34:53.280
Do it the proper way.
00:34:53.440 --> 00:34:57.679
I mean, a lot of them haven't even reached clinical trials these ones on the black market.
00:34:57.760 --> 00:35:00.400
They're still testing on rats, everybody listening in.
00:35:00.639 --> 00:35:02.880
So stay away from them.
00:35:03.599 --> 00:35:10.400
I mean, there's nothing wrong with rats and testing on rats and mice, but but you actually don't know what's in them.
00:35:10.559 --> 00:35:13.599
You you know, at the end of the day, you don't know what you're getting.
00:35:13.679 --> 00:35:17.519
And I think that that's that's um you're taking a risk.
00:35:17.760 --> 00:35:20.159
And is it worth taking the risk?
00:35:20.320 --> 00:35:21.679
Uh uh no.
00:35:22.400 --> 00:35:24.880
In my opinion, no, it's not worth taking that risk.
00:35:25.599 --> 00:35:28.880
I I think what it comes down to, Soph, is people are desperate.
00:35:29.119 --> 00:35:38.960
And not everyone can afford the the crazy prices that these are$500 or more or more, up to$700 and or even$800 a month for these drugs.
00:35:39.039 --> 00:35:45.840
And so they're desperate, but the long-term effects that you may not feel straight away are absolutely not worth it for your overall health.
00:35:46.000 --> 00:35:47.679
So that's what Sof's alluding to.
00:35:48.000 --> 00:35:50.719
Yeah, and I think uh I think Haley, you're right.
00:35:50.800 --> 00:36:00.559
I think we need to advocate, we need to all get together and advocate for governments to make them cheaper and to make them uh more uh readily available.
00:36:00.639 --> 00:36:04.000
Uh yeah, affordability, access and affordability.
00:36:04.559 --> 00:36:16.639
I could go on about the advocacy space because I don't even know if it's our government, it's more the pharmaceutical companies that have a role here to help the general population who these drugs are life-changing.
00:36:16.719 --> 00:36:27.599
Um, and there is that global war of if Australia drops the price, then we can't compete because other countries will want it lower, and then we lose our return on investment.
00:36:27.760 --> 00:36:30.000
Well, there's a health economics here.
00:36:30.079 --> 00:36:31.280
There's people at the end of the line.
00:36:31.360 --> 00:36:35.280
So that's my two cents worth to any pharma companies listening in.
00:36:36.559 --> 00:36:40.159
So, all right, let's bring this back to wounds soft.
00:36:40.400 -->
00:36:42.880
This is the area that I play in every day.
00:36:43.039 --> 00:36:50.400
What is it about diabetes that makes someone more vulnerable to developing a wound and having difficulty healing it?
00:36:50.880 --> 00:36:56.800
Yeah, it's it's a it's you know, as you know, it's a very um uh important question to ask.
00:36:56.960 --> 00:37:06.960
And I think the hypoglycemia plays a role uh in peripheral vascular disease, it plays a uh a role in in uh peripheral neuropathy.
00:37:07.280 --> 00:37:26.000
Uh and uh I think uh those two in combination then uh increase the propensity to uh somebody having with diabetes having uh uh a wound, and then that wound not being able to heal as quickly or as efficiently as it could.
00:37:26.480 --> 00:37:47.679
Uh I think uh in the first instance uh management of diabetes is important, that's one thing, and then the second thing is uh to always monitor and to always look at your feet and to always uh seek help advice before you develop uh a wound or before that wound gets gets infected.
00:37:47.760 --> 00:37:49.599
So a little bit more preventative.
00:37:50.239 --> 00:38:08.719
I tell people, irrespective of who they are, and I can tell you a friend of mine um a couple of weeks ago, uh, we caught up and said to me that his daughter, the 11-year-old daughter, got diagnosed with typon diabetes, um, which is fine, there's nothing you know, it happens, nothing unusual about that.
00:38:09.360 --> 00:38:13.119
They're getting great care at my shelf, which is wonderful.
00:38:13.280 --> 00:38:15.280
Uh and I'm really pleased.
00:38:15.440 --> 00:38:30.159
But one thing that I said to him is make sure your daughter does not walk barefoot, make sure your daughter always wears proper shoes, make sure your daughter always is wearing something when she's walking outside, particularly when it's hot, as you know, uh all that stuff.
00:38:31.199 --> 00:38:47.039
Not because she's gonna get a winter day tomorrow, but to get into those habits, to get into those good habits early on, uh, to make sure that we we sort of uh prevent anything that that happens uh um later on.
00:38:47.360 --> 00:39:02.079
Uh I think that, and I think then uh I think we need to sort of um empower, engage our uh GPs to when they see a person with type 2 diabetes, they also ask about their feet.
00:39:03.519 --> 00:39:05.360
Really sound information there.
00:39:05.440 --> 00:39:07.039
I like the habit forming actually.
00:39:07.119 --> 00:39:18.079
You've made me think about ways I could even alter some of my discussions with younger patients because they might not have neuropathy today, but it is a high prevalence for patients with diabetes.
00:39:18.239 --> 00:39:19.760
So it makes sense.
00:39:20.719 --> 00:39:26.719
And and there's nothing lost by saying, you know, just wear sandals or wear proper fitting shoes.
00:39:26.800 --> 00:39:29.760
Uh don't walk around bedfoot, basically.
00:39:29.840 --> 00:39:31.119
Yeah, please don't do that.
00:39:31.440 --> 00:39:32.559
Please be careful.
00:39:32.639 --> 00:39:40.719
I mean, you know, you're at home, the kids, they'll run around, you know, whatever, but just sort of try and get in that in in into that into that habit.
00:39:40.880 --> 00:39:42.960
I think we can go a long way.
00:39:43.360 --> 00:39:49.519
You know, you know, there's 6,600 amputations in Australia due to diabetes every year.
00:39:49.679 --> 00:39:57.119
And I think, you know, as we say uh through diabetes feed Australia, that most of those, if not all of those, are preventable, right?
00:39:57.360 --> 00:40:02.400
So so let's just get in the habit of trying to prevent those.
00:40:02.559 --> 00:40:09.679
Beyond that, I think, as I said, I think good uh blood glucose management and then making sure that you're getting your checks.
00:40:09.840 --> 00:40:19.199
Get your get your feet checked, get your um uh uh your um arterial um pulses checked.
00:40:19.360 --> 00:40:24.480
Uh I'm making uh I'm not making sense now, but you you can you can fill in the gaps, Haley, for me.
00:40:24.639 --> 00:40:25.280
Get your pulses checked.
00:40:25.440 --> 00:40:28.400
Yeah, you are you are through your Doppler, Doppler ultrasounds for sure.
00:40:28.639 --> 00:40:34.800
Doppler ultrasound and get your your uh thingos checked with the um uh uh with with the filaments.
00:40:36.159 --> 00:40:39.920
Oh the fil the microfilaments, the microfilament checking for the neuropathy, yes.
00:40:42.239 --> 00:40:44.159
Um totally making sense.
00:40:44.400 --> 00:40:48.719
Um if I think about uh a lot of the patients I have, right?
00:40:48.880 --> 00:40:53.679
Once someone already has a wound, how much does glucose control actually matter?
00:40:53.760 --> 00:40:55.360
And I'm gonna give you an example.
00:40:55.599 --> 00:41:12.079
So many of my patients will say, Oh, I'm sitting at 8.5, I've been sitting at 8.5 for a whole year, but it's just been the last month that they've had a wound and they still consider that's okay because that's what they've normally had as in an elevated um sugar level, but now they have a wound.
00:41:12.239 --> 00:41:16.639
So how much does glucose control actually matter for someone with a wound?
00:41:16.960 --> 00:41:18.880
Yeah, it's a it's a it's a very good question.
00:41:18.960 --> 00:41:21.599
It's a question that I that I ask a lot of people.
00:41:21.760 --> 00:41:41.679
You know, once you get a wound, yeah, how much does uh diabetes matter versus treating the actual wound itself and getting that um de bright and getting that cleaned and getting that uh with with the appropriate medications and antibiotics and so on.
00:41:42.800 --> 00:41:45.360
My feeling is that diabetes still matters.
00:41:45.440 --> 00:41:53.440
My my feeling is that if you can continue to manage your your blood glucose levels well, then that cannot hurt, right?
00:41:53.519 --> 00:42:14.000
That that that would obviously have some sort of benefit, even if you have
peripheral neuropathy, even if you have uh uh a wound uh that requires attention, I would think that managing blood glucose levels would still make some sort of difference and would still be of benefit.
00:42:14.239 --> 00:42:17.199
You know, bugs love sugar.
00:42:17.440 --> 00:42:24.639
Uh and so we can probably do well by not having uh sugar for those bugs to love.
00:42:25.280 --> 00:42:30.400
So so uh I would think that that it's probably um very important.
00:42:32.400 --> 00:42:38.400
All right, well, you've been also heavily involved in this great program called the Foot Forward Program.
00:42:38.719 --> 00:42:40.880
What can you tell our listeners about it?
00:42:41.199 --> 00:42:56.000
So the foot forward program is funded by the National Diabetes Services Scheme, which is a Department of Health, a federal government uh scheme uh that Diabetes Australia manages on behalf of uh the uh government.
00:42:56.159 --> 00:43:00.079
There's a number of components that so sorry, so I should go back a step back.
00:43:00.159 --> 00:43:02.480
Uh there's two components to Foot Forward.
00:43:02.639 --> 00:43:07.760
There's a um lived experience or consumer component, and then there's the health professional component.
00:43:07.840 --> 00:43:14.559
And within the health professional component, there's a number of uh resources or a number of activities that we've done.
00:43:14.639 --> 00:43:21.920
Uh one of them is about uh pathways and integrated pathways, and there's uh there's two main pathways.
00:43:22.000 --> 00:43:29.440
There's the management pathway, and then there's the prevention pathway, and they're color-coded, and they're really, really good.
00:43:29.679 --> 00:43:34.480
Uh, footforward.org org.au if you want to get the resources.
00:43:34.639 --> 00:43:36.559
And then there's an educational component.
00:43:36.639 --> 00:43:59.360
So we've put together uh educational modules uh for nurses, for podiatrists, for aboriginal and Torres Island health workers, uh uh, which takes you through everything that we talked about today about um screening, diagnosis, what the peripheral neuropathy is, what peripheral arterial disease is, uh, how to manage it, how to test for it.
00:43:59.519 --> 00:44:26.079
Um the LOPS, the the um angle um um um uh pulses uh excellent uh outstanding uh um educational modules that it you can do and they're for free uh and they're available um for everybody to do uh and then there's webinars and then there's uh other resources on the website that you can uh access.
00:44:26.480 --> 00:44:28.639
Um uh I'm biased.
00:44:28.880 --> 00:44:37.440
Uh yeah Natalie we should put this together on behalf of the ADS um uh I think she's done an outstanding job.
00:44:37.599 --> 00:44:43.199
Uh I think they're really great resources and I think we should be um uh trying to implement them.
00:44:43.360 --> 00:45:47.039
The other um uh component to Foot Forward is train the trainer so you can get resources by which you can then train local health uh workers um uh to be able to screen and manage uh diabetes-related foot disease and I would encourage that that's that was put together uh specifically for um rural remote uh communities and and health services where getting specialist care may not be as accessible as possible you can get the train the trainer um uh resources to be able to then uh apply upskill your your local um health uh workers to to to be able to manage people in that community i've I've actually personally had a look at the resources and they are phenomenal there is so much information there we will put into the show notes uh the link of where you can go to to access those resources and I highly encourage everybody listening in to get over there and have a look because it's brilliant.
00:45:47.199 --> 00:45:52.159
So well done Soph and and the team and your colleagues for putting that all together.
00:45:52.960 --> 00:45:57.679
Soph, I want to get into what this uh podcast is really about and that's the controversial question.
00:45:57.760 --> 00:46:15.760
So I'm gonna kick it off with asking is calling type 2 diabetes a lifestyle disease scientifically inaccurate and potentially harmful yes it's inaccurate and harmful because it stigmatizes people.
00:46:16.159 --> 00:48:06.400
Type 2 diabetes is a disease of the beta cell not secreting enough insulin the appropriate amount of insulin for the prevailing insulin resistance and the insulin resistance is likely to be lifestyle so can you improve things by uh um putting uh in place lifestyle measures yes you can uh but uh type2 diabetes is a better cell dysfunction disease which is caused by your genetics yeah absolutely so are then clinicians here's the next question too focused on HBA1C uh no I think we are focused on HBA1C I think uh perhaps um uh um yeah I was gonna I'm gonna say appropriately uh on HBA1C but we can do better now with that we've got CGM we can do better we can get better uh measures of uh blood glucose management so I would say HPI1C is still very very relevant and important in type 2 diabetes and in type 1 diabetes but I think we can get much more nuanced much more granular information if we use CGM and make uh specific changes to people's uh management of the diabetes which probably it would be a lot more effective all right then perhaps one of the biggest questions that comes to mind with all the medications the technology that's out there we've spoken about some guidelines that are available you've mentioned how many you're involved with and the knowledge we have why are people still developing these complications and type 2 diabetes besides the genetics component because we don't know the underlying cause of disease and the drugs that we have do not treat the underlying cause of disease.
00:48:06.559 --> 00:48:16.800
Even the GLP1 based therapies which we've just spoken about do not treat the underlying cause of disease because we honestly do not know what it is.
00:48:16.960 -->
00:48:27.519
So for me the way that I look at the management of diabetes even today with these wonderful drugs that we have is that they are band-aid measures.
00:48:27.840 --> 00:48:52.400
They don't treat the underlying cause of disease can we um they're not durable in other words they're not durable so yes you're gonna get good glycemic management for a period of time and things will look well for a period of time but it is a progressive disease and blood glucose levels do increase at certain times and you do get you do need more and more medication.
00:48:52.480 --> 00:53:19.280
So that's why we still have complications all right let's look to the future then the Australian Diabetes Society is involved in the national diabetes research strategy for 2026 to 2035 what are the big questions we still need diabetes research to answer in your opinion well I I I think um yeah what causes uh type 1 diabetes uh what causes type 2 diabetes um uh why do some people develop complications while other people may not develop as severe complications um uh what are the interventions that we can put in place that are sustainable and that are of benefit uh we've spoken a little bit about lifestyle okay uh what's the appropriate lifestyle uh what's the appropriate diet we still don't know uh whether um you know I'm I'm gonna be again controversial given this is the controversial part we still don't know whether a low carb high fat diet is the right diet for diabetes uh it probably suits some people it may not suit other people and I've gotten uh into trouble in the past for saying these uh making these comments I don't think um uh we should uh completely eliminate uh carbs from a diet I would uh encourage people to um seek uh advice uh get a um an accredited uh dietitian uh to to help you with your diabetes uh management and your lifestyle and your and your uh dietary um requirements uh I think you know how does insulin resistance uh influence beta cell failure we still don't know that why does the immune system um attack the beta cells and kills kill the beta cells in type 1 diabetes we still don't know the answer to that uh are uh in type 1 diabetes we now have uh immune modulatory therapies that can um delay the onset of type 1 diabetes for a little bit of time can we really really delay type 1 can we prevent type 1 diabetes uh can we prevent type 2 diabetes uh um uh I think these are questions that that yeah are really really important uh you know what what causes beta cell dysfunction can we can we uh target that cause with an intervention to be able to then preserve beta cell function mass to to make management of types of diabetes better uh easier so so many questions still to be answered so for all the years you've been working in the field so many to go you know and I all of the research that I've read and I am not a dietitian I'd agree with sof consult a dietitian but everything always leads back to the Mediterranean diet so you know I think there's something in that sof us Greeks you know we we peaked two and a half thousand years ago but we're still we're on the way back now and and it always goes back to the Greeks as well so back to the Greeks of course uh and feta cheese and tzatziki uh uh you know and and tomatoes you know olives you know you can't you can't go you can't go wrong you know you can't go wrong I have to agree give me a word and I can tell you how it's come from the Greeks give me a word I know I know that's true we could do a whole other podcast on that stuff I love it so I have one final question for you look you've spent your career looking at diabetes from the laboratories laboratory to research to clinical care now at a national policy level so if every healthcare professional listening in could change one thing tomorrow that would generally reduce the future burden of diabetes and its complications what would you want them to focus on uh when you diagnose a person with diabetes whichever form of diabetes it is please manage them in a more proactive manner I was gonna say aggressive but in a more proactive manner.
00:53:19.519 --> 00:53:34.079
We know from all the trials that the the better management of diabetes particularly early on the more likely you're going to reduce the risk of complications later in the disease process.
00:53:34.239 --> 00:54:22.239
So the one thing that I would say would be to be proactive and manage the people's diabetes as effectively and efficiently as possible try and normalize uh or try and reduce blood glucose HBA1Cs as much as you possibly can at that early stage be proactive well yes totally agree just do it just do it you've heard it here first just do it I agree with you all right so a wound is never just a wound it's the walk that never happened the grandchild that couldn't chase the confidence they slowly lost at wound rescue we see more than the wound.
00:54:22.400 --> 00:54:54.719
We bring advanced wound care directly to homes, aged care, general practice and communities across Australia because we're healing lives not just wounds call 1300 19315 or visit woundrescue.com.au today we're going to finish with uh a segment we call rapid fire this is where we get to unwrap whether something is true or false but the kicker here soft is there's no time to elaborate you have to think quick and it's about having a bit of fun.
00:54:54.880 --> 00:56:25.760
How does that sound uh I'm all for fun all right let's kick it off true or false type two diabetes is primarily a lifestyle disease false genetics plays an important role in someone's risk of developing type 2 diabetes very true a good HBA1c always means someone's diabetes is well controlled false everyone with type 2 diabetes should be using a CGM true yeah true type 2 diabetes can go into remission true losing weight automatically cures type 2 diabetes false false technology false false false technology alone will solve Australia's diabetes problem false and finally we should be optimistic about the future of diabetes care uh a hundred percent true uh no doubts in that absolutely true thank you soft thank you so much for joining us it's been fascinating to take the conversation beyond diabetes complications and really understand the disease behind them I think your ability to bring together the science the research and the bigger picture of diabetes care has given us all something to think about.
00:56:26.159 --> 00:56:40.000
I want to thank you for sharing your knowledge your time with us and for continuing to do what you are doing to shape diabetes in um in in Australia it's been an absolute pleasure with having you on Wundcare Unwrapped.
00:56:40.559 --> 00:57:25.360
Thank you thank you Haley thank you for the opportunity thank you for having me thank you for for um addressing to me a very important topic you know there's 1.5 million people with uh diabetes in Australia all forms of diabetes probably more with the undiagnosed people I think it's an important topic so thank you for uh shining the light uh uh on diabetes and for giving me the opportunity to to discuss it with you thanks so much Soph thank you for tuning in to this episode of woundcare unwrapped you can find us on LinkedIn Facebook Instagram and TikTok at wound rescue pty ltd a big thank you to our show partners at Learn on the move you can find more about them in our show notes.
00:57:25.519 --> 00:57:33.920
Now woundcare changes when we start having real conversations and that's why we believe it's about healing lives and not just wounds.
00:57:34.079 --> 00:57:38.239
Tune in for next week's episode of Woundcare Unwrapped